These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 1423273

  • 21. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 22. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 01; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 23. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May 01; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 24. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.
    Gunji H, Kharbanda S, Kufe D.
    Cancer Res; 1991 Jan 15; 51(2):741-3. PubMed ID: 1985792
    [Abstract] [Full Text] [Related]

  • 25. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB, Tong WP, Chou TC.
    Mol Pharmacol; 1991 Feb 15; 39(2):250-7. PubMed ID: 1705001
    [Abstract] [Full Text] [Related]

  • 26. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS, Baker VV, May WS.
    Oncogene; 1987 May 15; 1(2):111-8. PubMed ID: 3325877
    [Abstract] [Full Text] [Related]

  • 27. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
    Wall NR, Mohammad RM, Nabha SM, Pettit GR, Al-Katib AM.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):76-80. PubMed ID: 10581168
    [Abstract] [Full Text] [Related]

  • 28. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE.
    Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938
    [Abstract] [Full Text] [Related]

  • 29. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM.
    Clin Cancer Res; 2000 Dec 01; 6(12):4950-6. PubMed ID: 11156256
    [Abstract] [Full Text] [Related]

  • 30. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Jarvis WD, Fornari FA, Tombes RM, Erukulla RK, Bittman R, Schwartz GK, Dent P, Grant S.
    Mol Pharmacol; 1998 Nov 01; 54(5):844-56. PubMed ID: 9804619
    [Abstract] [Full Text] [Related]

  • 31. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L).
    Wang Z, Wang S, Dai Y, Grant S.
    J Pharmacol Exp Ther; 2002 May 01; 301(2):568-77. PubMed ID: 11961058
    [Abstract] [Full Text] [Related]

  • 32. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 33. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 34. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 15; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 35. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S.
    Exp Cell Res; 1998 Oct 10; 244(1):105-16. PubMed ID: 9770354
    [Abstract] [Full Text] [Related]

  • 36. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A.
    Clin Cancer Res; 1998 May 10; 4(5):1337-43. PubMed ID: 9607595
    [Abstract] [Full Text] [Related]

  • 37. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar 10; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 38. Varied differentiation responses of human leukemias to bryostatin 1.
    Kraft AS, William F, Pettit GR, Lilly MB.
    Cancer Res; 1989 Mar 01; 49(5):1287-93. PubMed ID: 2917358
    [Abstract] [Full Text] [Related]

  • 39. Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates.
    Studzinski GP, Reddy KB, Hill HZ, Bhandal AK.
    Cancer Res; 1991 Jul 01; 51(13):3451-5. PubMed ID: 2054784
    [Abstract] [Full Text] [Related]

  • 40. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH.
    Cancer Res; 1989 Nov 01; 49(21):5870-8. PubMed ID: 2790800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.